CMRA Insider Trading

Insider Ownership Percentage: 4.50%
Insider Buying (Last 12 Months): $606,301.57
Insider Selling (Last 12 Months): $0.00

Comera Life Sciences Insider Trading History Chart

This chart shows the insider buying and selling history at Comera Life Sciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Comera Life Sciences Share Price & Price History

Current Price: $1.34
Price Change: Price Decrease of -0.01 (-0.74%)
As of 02/2/2023 01:00 AM ET

This chart shows the closing price history over time for CMRA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Comera Life Sciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/4/2023David SoaneMajor ShareholderBuy202,701$1.23$249,322.233,336,562View SEC Filing Icon  
11/8/2022David SoaneMajor ShareholderBuy3,000$1.38$4,140.003,268,995View SEC Filing Icon  
10/20/2022Charles CheringtonMajor ShareholderBuy3,316$1.52$5,040.32638,246View SEC Filing Icon  
10/17/2022Charles CheringtonMajor ShareholderBuy15,266$1.66$25,341.56634,930View SEC Filing Icon  
10/13/2022Charles CheringtonMajor ShareholderBuy10,481$1.66$17,398.46615,411View SEC Filing Icon  
9/29/2022Charles CheringtonMajor ShareholderBuy17,900$1.87$33,473.00604,930View SEC Filing Icon  
9/27/2022Charles CheringtonMajor ShareholderBuy12,000$1.69$20,280.00587,030View SEC Filing Icon  
9/12/2022James SherblomDirectorBuy50,000$2.03$101,500.00371,163View SEC Filing Icon  
9/9/2022Jeffrey S HackmanInsiderBuy47,600$2.06$98,056.0047,600View SEC Filing Icon  
9/8/2022Michael Gerard CampbellCFOBuy25,000$2.07$51,750.0025,000View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Comera Life Sciences (NASDAQ:CMRA)

2.94% of Comera Life Sciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CMRA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Comera Life Sciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/15/2022Lake Street Advisors Group LLC316,469$0.51M0.0%+216.5%2.390%Search for SEC Filing on Google Icon
11/14/2022Bluefin Capital Management LLC19,584$32K0.0%-28.8%0.148%Search for SEC Filing on Google Icon
11/7/2022Virtu Financial LLC15,354$25K0.0%N/A0.116%Search for SEC Filing on Google Icon
11/2/2022Arena Investors LP84,944$0.14M0.1%N/A0.642%Search for SEC Filing on Google Icon
8/16/2022Jane Street Group LLC43,624$0.12M0.0%N/A0.329%Search for SEC Filing on Google Icon
8/15/2022Bluefin Capital Management LLC27,511$73K0.0%N/A0.208%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Comera Life Sciences logo
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its primary product programs, CLS-001, a preclinical stage biobetter for Crohn's and Ulcerative Colitis disease, and CLS-002, a preclinical stage biobetter for various oncology indications. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.
Read More on Comera Life Sciences

Today's Range

Now: $1.34
Low: $1.30
High: $1.43

50 Day Range

MA: $1.40
Low: $1.20
High: $1.90

52 Week Range

Now: $1.34
Low: $1.11
High: $11.44


47,998 shs

Average Volume

124,677 shs

Market Capitalization

$26.60 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Comera Life Sciences?

Comera Life Sciences' top insider investors include:
  1. David Soane (Major Shareholder)
  2. Charles Cherington (Major Shareholder)
  3. James Sherblom (Director)
  4. Jeffrey S Hackman (Insider)
  5. Michael Gerard Campbell (CFO)
Learn More about top insider investors at Comera Life Sciences.